SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Novartis India

Novartis India

BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Aug 24, 12:37
718.00
15.45 (+2.20%)
VOLUME 26,648
AVERAGE VOLUME
5-Day 13,030
10-Day 9,722
30-Day 14,957
VOLUME SHOCKER
5-Day 13,030
10-Day 9,722
30-Day 14,957
Prev. Close
702.55
Open Price
707.40
Bid PRICE (QTY.)
716.35 (3)
Offer PRICE (Qty.)
717.90 (50)
VWAP 715.31
Market
Depth

Market Depth (24 Aug 2016)

BUY SELL
QTY PRICE PRICE QTY
3 716.35 717.00 1
1 716.30 717.90 50
108 716.25 718.00 112
10 716.00 718.95 5
23 715.95 719.00 10
14.51 K Total 13.85 K Total

Buy Qty

14.51 K

Sell QTY

13.85 K

Today's Low/High 705.00 722.00
52 Wk Low/High 600.00 967.75
L/U Price Band 562.05 843.05

Novartis India is not traded on NSE in the last 30 days

Action in Novartis India

Novartis India
Sentimeter

100%
BUY

100% of moneycontrol users recommend buying Novartis India. What's your call on Novartis India today?
Read 5 investor views

Standalone
MARKET CAP (Rs Cr)
2,294.79
P/E
11.24
BOOK VALUE (Rs)
363.61
DIV (%)
200.00%
Market Lot
1
INDUSTRY P/E
27.86
EPS (TTM)
63.90
P/C
11.04
PRICE/BOOK
1.97
DIV YIELD.(%)
1.39%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
68.35 new
DELIVERY AVERAGES
3-Day 65.51%
5-Day 65.80%
8-Day 66.93%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Novartis India on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

19 July 2016

buy

Ceat Jul Fut

Entry Price (Rs)

884.00

Exit Price (Rs)

893.00

Gain (Rs)

9.00

buy

DrReddysLabs Jul Fut

Entry Price (Rs)

3,580.00

Exit Price (Rs)

3,613.00

Gain (Rs)

33.00

sell

Glenmark Jul Fut

Entry Price (Rs)

847.00

Exit Price (Rs)

836.00

Gain (Rs)

11.00

buy

BajajAuto Jul Fut

Entry Price (Rs)

2,741.00

Exit Price (Rs)

2,759.00

Gain (Rs)

18.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 875.00 707.40  
High Price 881.00 722.00  
Low Price 854.10 705.00  
Last Price 873.30 718.00 -17.78
Volume 21,509 26,648 23.89
Simple Moving Averages
Days BSE NSE
30 706.43
50 707.80
150 707.80
200 738.21

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Novartis India

The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
Pre Opening Session Prices 9:00 - 9:15
BSE
Aug 24, 09:09
707.40
4.85 (+0.69%)
High
708.00
Low
702.55
NSE - No shares traded
News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Jun'16 Mar'16 Dec'15
Sep'15
Net Sales 158.62 153.61 183.38 215.44
Other Income 21.22 21.00 21.63 20.04
PBDIT 9.28 10.73 -0.12 11.60
Net Profit 19.07 21.53 59.81 103.82

Annual Report

Download in PDF format 2015 |2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'16
(In Rs Cr)
Total Share Capital 15.98
Net Worth 1,162.13
Total Debt 0.00
Net Block 6.47
Investments 0.01
Total Assets 1,162.13
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 771.00 1.11 940.40 706.40 185,560.73
Lupin 1518.00 -2.36 2127.00 1294.05 68,458.93
Dr Reddys Labs 3027.00 0.63 4382.95 2750.00 51,670.53
Cipla 566.40 2.06 704.75 458.25 45,516.50
Aurobindo Pharm 770.25 4.61 891.50 618.00 45,072.69
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 16Dec' 15Sep' 15Jun' 15
Promoter75.0075.0075.0075.00
Public (FII + DII)25.0025.0025.0025.00
Others0.000.000.000.00
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Sandoz House, Shivsagar Estate,,Dr Annie Besant Road,
City
Mumbai
State
Maharashtra
Pin Code
400018
Tel. No.
22-24958400 22-24958888
Fax No.
24950221
REGISTRARS
Name
Sharepro Services (India) Pvt.Ltd.
Address
13 AB, Samhita Warehousing Complex, 2nd Floor, Sakinaka Telephone Exchange Lane, Off Andheri-Kurla Road, Sakinaka, Andheri (E)
City
Mumbai - 400072
State
Maharashtra
Tel. No.
022-67720300, 67720400
Fax No.
022-28591568, 28508927
MANAGEMENT
Name
Designation
Christopher Snook
Chairman
Ranjit Shahani
Vice Chairman & Mng.Director
Monaz Noble
Whole Time Director
Jai Hiremath
Director
Rajendra Nath Mehrotra
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Jai Corp Limited Recommended on Jul 1st 2016

Recommended price 76.00  |  Peak from reco 84.40 11.79%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Novartis India

Novartis India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,294.79 crore.

The company management includes Christopher Snook - Chairman, Ranjit Shahani - Vice Chairman & Mng.Director, Monaz Noble - Whole Time Director, Jai Hiremath - Director, Rajendra Nath Mehrotra - Director, Sandra Martryes - Additional Director.

It is listed on the BSE with a BSE Code of 500672 and the NSE with an NSE Code of NOVARTIND.

Its Registered office is at Sandoz House, Shivsagar Estate,,Dr Annie Besant Road, Mumbai,Maharashtra - 400018.

Their Registrars are Sharepro Services (India) Pvt.Ltd.

Quick Links for Novartis India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Novartis India